OrthoPediatrics (NASDAQ:KIDS) Trading Up 6.1% – Time to Buy?

OrthoPediatrics Corp. (NASDAQ:KIDS)’s share price was up 6.1% during trading on Tuesday . The company traded as high as $24.34 and last traded at $24.20. Approximately 91,979 shares were traded during trading, a decline of 45% from the average daily volume of 167,614 shares. The stock had previously closed at $22.81.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a research report on Friday, November 8th. Truist Financial lowered their price target on OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a research report on Monday, October 14th. Finally, JMP Securities reissued a “market outperform” rating and issued a $50.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th.

OrthoPediatrics Stock Performance

The company has a fifty day moving average of $26.67 and a two-hundred day moving average of $29.42. The firm has a market capitalization of $640.86 million, a price-to-earnings ratio of -21.24 and a beta of 1.16. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

Institutional Investors Weigh In On OrthoPediatrics

A number of institutional investors have recently modified their holdings of KIDS. Quarry LP bought a new stake in shares of OrthoPediatrics in the third quarter valued at approximately $25,000. International Assets Investment Management LLC raised its holdings in OrthoPediatrics by 2,610.8% in the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after acquiring an additional 966 shares in the last quarter. Quest Partners LLC bought a new stake in shares of OrthoPediatrics during the 2nd quarter valued at $34,000. EntryPoint Capital LLC grew its holdings in shares of OrthoPediatrics by 56.9% during the 1st quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock worth $81,000 after purchasing an additional 1,009 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its position in shares of OrthoPediatrics by 125.1% in the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after purchasing an additional 1,929 shares during the period. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.